the use of magnesium sulfate nebulization in patient with moderate to severe asthma exacerbation in pediatric emergency
follow asthma severity score and length of stay
Age
2–14
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Pediatric asthma patients with moderate to severe exacerbation
You may not be if
Known allergy to magnesium sulfate
History of neuromuscular disease, cardiac disease, renal disease, or underlying chronic lung disease
Use of oral steroid medication within 72 hours of presentation
Radiographic evidence of pneumonia at presentation
Administration of intravenous magnesium sulfate prior to study enrollment
